Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) U... by Moorman, A, Harrison, C, Richards, S, Fielding, A, Tallman, MS, Litzow, MR, Rowe, J, Goldstone, A, Dewald, G

Does imatinib change the outcome in philapdelphia chromosome positive acute lympooblastic leukaemia in adults? Data from the UKALLXII/ECOG2993 study by Fielding, A, Richards, S, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Rowe, J, Tallman, MS, Goldstone, A

Outcome in Philadelphia Chromosome Positive (Ph plus ) Adult ALL Patients (Pts) May Be More Determined by CD25 Expression Than by Ph Status Per Se by Paietta, E, Li, X, Richards, S, Racevskis, J, Dewald, G, Rowe, J, Tallman, MS, Lazarus, H, Litzow, MR, Goldstone, A, Wiernik, P

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Adult patients with acute lymphoblastic leukemia (ALL) and central nervous system (CNS) leukemia at diagnosis may attain durable complete remissions (CR). Results from the internat... by Lazarus, H, Richards, S, Chopra, R, Litzow, MR, Burnett, A, Wiernik, P, Franklin, I, Tallman, MS, Buck, G, Durrant, J, Rowe, J, Goldstone, A

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Induction therapy for adults with acute lymphoblastic leukemia (ALL): Results of nearly 1,400 patients from the international ALL trial (MRC UKALL XII/ECOG E2993). by Rowe, J, Buck, G, Burnett, A, Chopra, R, Wiernik, P, Richards, S, Lazarus, H, Franklin, I, Litzow, MR, Prentice, H, Durrant, J, Tallman, MS, Goldstone, A

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

The outcome of 551 1(st) CR transplants in adult ALL from the UKALL XII/ECOG 2993 study by Goldstone, A, Lazarus, H, Richards, S, Litzow, MR, Chopra, R, Burnett, A, Wiernik, P, Franklin, I, Prentice, H, Tallman, M, Harrison, G, Durrant, J, Rowe, J

Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial by Fielding, A, Buck, G, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Tallman, MS, Rowe, J, Goldstone, A

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial by Fielding, A, Buck, G, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Tallman, MS, Rowe, J, Goldstone, A

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial by Fielding, A, Buck, G, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Tallman, MS, Rowe, J, Goldstone, A

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. by Lazarus, H, Richards, S, Chopra, R, Litzow, MR, Burnett, A, Wiernik, P, Franklin, I, Tallman, MS, Cook, L, Buck, G, Durrant, I, Rowe, J, Goldstone, A

Integrative Genome Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia by Geng, H, Neuberg, D, Paietta, E, Deng, X, Li, Y, Xin, Y, Racevskis, J, Ketterling, R, Richards, S, Tallman, MS, Rowe, J, Litzow, MR, Elemento, O, Melnick, A

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. by Fielding, A, Richards, S, Chopra, R, Lazarus, H, Litzow, MR, Buck, G, Durrant, I, Luger, S, Marks, D, Franklin, I, McMillan, A, Tallman, MS, Rowe, J, Goldstone, A

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. by Rowe, J, Buck, G, Burnett, A, Chopra, R, Wiernik, P, Richards, S, Lazarus, H, Franklin, I, Litzow, MR, Ciobanu, N, Prentice, H, Durrant, J, Tallman, MS, Goldstone, A

Integrative Genome-Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia by Geng, H, Neuberg, D, Paietta, E, Deng, X, Li, Y, Xin, Y, Racevskis, J, Ketterling, R, Richards, S, Tallman, MS, Rowe, J, Litzow, MR, Elemento, O, Melnick, A

Integrative Genome Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia by Geng, H, Neuberg, D, Paietta, E, Deng, X, Li, Y, Xin, Y, Racevskis, J, Ketterling, R, Richards, S, Tallman, MS, Rowe, J, Litzow, MR, Elemento, O, Melnick, A

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. by Fielding, A, Rowe, J, Buck, G, Foroni, L, Gerrard, G, Litzow, MR, Lazarus, H, Luger, S, Marks, D, McMillan, A, Moorman, A, Patel, B, Paietta, E, Tallman, MS, Goldstone, A